Autres langues Cogstate Limited

Actions

CGS

AU000000CGS8

Recherche biotechnologique et médicale

Temps Différé Australian S.E. Autres places de cotation 07:35:08 10/08/2026			Varia. 5j.	Varia. 1 janv.
2,670 ^AUD	+3,09%		+6,37%	+18,14%

08/07	Cogstate : hausse des nouveaux contrats de vente au trimestre clos en juin	MT
10/06	Transcript : Cogstate Limited - Special Call

Autres langues

08/07	Cogstate's June Quarter Net Sales Contracts Rises
22/05	Cogstate Limited Announces Changes in Joint Company Secretary Positions Effective May 22, 2026
23/04	Cogstate Limited Announces Board and Committee Changes
08/04	Cogstate Says Nine-Month Total Sales Contracts Reach $67.1 Million, Shares Up 6%
08/04	Cogstate posts 3Q26 sales contracts executed total $25.4 million
18/02	Cogstate Limited Provides Revenue Guidance for the Second Half of Fiscal Year 2026
18/02	Tranche Update on Cogstate Limited's Equity Buyback Plan announced on November 11, 2025.
18/02	Cogstate Limited Reports Earnings Results for the Half Year Ended December 31, 2025
22/01	Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%
21/01	Cogstate Limited Revises Earnings Guidance for the First Half Year Ended 31 December 2025
10/12	Cogstate Ltd forecasts 1H26 revenue at $25-$26 million
10/12	Cogstate Says Timing-Related Revenue Deferrals to Impact Fiscal Year 2026 First Half Reported Revenue, Profitability; Shares Plunge 22%
09/12	Cogstate Limited Provides Earnings Guidance for the Half-Year Ending 31 December 2025
11/11	Cogstate Limited announces an Equity Buyback for 16,888,479 shares, representing 10% of its issued share capital.
11/11	Cogstate to extend share buyback
11/11	Cogstate to Extend Share Buyback Program; Shares Up 3%
11/11	Cogstate Limited authorizes a Buyback Plan.
11/11	Cogstate Limited's Equity Buyback announced on October 21, 2024, has expired with 5,870,804 shares, representing 3.41% for AUD 7.65 million.
10/11	Tranche Update on Cogstate Limited's Equity Buyback Plan announced on October 21, 2024.
07/11	ASX Midday Sector Update: Healthcare Stocks Up, Information Technology Sector Declines
07/11	Cogstate Says CNS Clinical Trial Segment to Grow to AU$1.3 Billion by Fiscal 2030
17/10/25	Cogstate CEO Sells Shares to Fund Exercise of Employee Share Options
16/10/25	Cogstate September Quarter Contract Value Rises, Sees Higher Fiscal H1 Revenue; Shares Hit 52-Week High
16/10/25	Cogstate says not possible to provide accurate FY26 guidance at this stage
22/08/25	Cogstate posts FY revenue USD 53.1 million